ICON partners with Anthropic to integrate Claude AI into clinical trials
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials
July 28, 2026 7:00 AM EDTDUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR) today announced a multi-year collaboration with Anthropic to bring Claudes AI capabilities across the clinical trial lifecycle. The collaboration further advances ICONs digital innovation and AI strategy, and builds on Orbis ICONs secure, governed, agentic AI platform.
Through this collaboration, ICON will work closely with Anthropics Life Sciences research team to explore and apply cutting-edge technologies that can accelerate innovation across clinical development.
With support from Anthropic, ICON will develop four production capabilities within Orbis:
Site... More